The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives

Background: In the recent years, immunotherapeutics and specifically immune-checkpoints inhibitors have marked a significant shift in the diagnostic and therapeutic algorithm of Non-Small Cell Lung Cancer (NSCLC), allowing us to use immunotherapeutics alone or combined with chemotherapy for a great...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocco, Danilo, Gravara, Luigi D., Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497556/
https://www.ncbi.nlm.nih.gov/pubmed/31400270
http://dx.doi.org/10.2174/1574884714666190809124555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497556/
https://www.ncbi.nlm.nih.gov/pubmed/31400270
http://dx.doi.org/10.2174/1574884714666190809124555

Ejemplares similares